Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). (Q34756419)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). |
scientific article |
Statements
1 reference
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). (English)
1 reference
Peter A LeWitt
1 reference
M Guttman
1 reference
James W Tetrud
1 reference
Paul J Tuite
1 reference
Akihisa Mori
1 reference
Philip Chaikin
1 reference
Neil M Sussman
1 reference
6002-US-005 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference